Research Topics
| Ray SpierSummaryAffiliation: University of Surrey Country: UK Publications
| Collaborators |
Detail Information
Publications
Peer review and innovationRaymond E Spier
School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey GU2 7XH, United Kingdom
Sci Eng Ethics 8:99-108; discussion 109-12. 2002....
Reflections on 'Real Science: What it is, and what it means' by John ZimanRaymond Spier
School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey GU2 7XH, United Kingdom
Sci Eng Ethics 8:235-52; discussion 253-5. 2002..The continuation of this discussion into the future is clearly called for; its outcome is less apparent...
Ethical aspects of the methods used to evaluate the safety of vaccinesR E Spier
School of Biomedical and Molecular Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK
Vaccine 22:2085-90. 2004
Animal and plant cell technology: a critical evaluation of the technology/society interfaceR E Spier
University of Surrey, Guildford, UK
J Biotechnol 65:111-25. 1998..It focuses on the role of the regulatory agency and on the need for biotechnologists to acquire professional status so that they may develop a more trustworthy relationship with society...
Conference summary: 'The responsible conduct of basic and clinical research'Raymond E Spier
School of Biological and Medical Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK
Sci Eng Ethics 12:189-97. 2006
On the need for, and the delivery of, cross-protective vaccinesR E Spier
University of Surrey, School of Biomedical and Life Sciences, Guildford, Surrey GU2 7XH, UK
Vaccine 23:2027-9. 2005....
Observations on a meeting on the ethics of intellectual property rights and patentsRaymond Spier
School of Biological and Molecular Sciences, University of Surrey, Guildford, Surrey GU2 7XH, United Kingdom
Sci Eng Ethics 11:151-8. 2005
Human genetic testing under examination by the European Union. Report on a citizens' and stakeholders' conference on "human genetic testing, what implications?"Raymond Spier
Emeritus Professor of Science and Engineering Ethics, University of Surrey, Guildford, Surrey GU2 7XH, UK
Sci Eng Ethics 10:579-86. 2004
Placebo: its action and place in health research today--summary and conclusionsRaymond E Spier
School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey GU2 7XH, United Kingdom
Sci Eng Ethics 10:189-97. 2004
Additional thoughts on the funding of poliovirus research: some reflections stimulated by "Parallel path: poliovirus research in the vaccine era" (M.S. Garfinkel and D. Sarewitz)Raymond E Spier
School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK
Sci Eng Ethics 9:340-2. 2003
Perception of risk of vaccine adverse events: a historical perspectiveR E Spier
School of Biological Sciences, University of Surrey, GU2 7XH, Surrey, Guildford, UK
Vaccine 20:S78-84; discussion S75-7. 2001..The concerns which such movements raise and ways in which they may be addressed are dealt with in the final sections...
The history of the peer-review processRay Spier
School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey, UK GU2 7XH
Trends Biotechnol 20:357-8. 2002..On the one side, we have the writers and originators of ideas, on the other, we have the editors and critics. But it was not always so...
Words are toolsRaymond E Spier
Sci Eng Ethics 10:595-6. 2004
The British public speaksRaymond E Spier
Sci Eng Ethics 11:163-5. 2005
On the management of funding of research in science and engineeringRaymond E Spier
Sci Eng Ethics 9:298-300. 2003
Some thoughts on the 2007 World Conference on Research IntegrityRaymond E Spier
Sci Eng Ethics 13:383-6. 2007
A conflict of interest disclosure policy for science and engineering ethicsStephanie J Bird
Sci Eng Ethics 14:149-52. 2008
